PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19595129-8	2009	RESULTS: The mPAP of the simvastatin intervention group was (23 +/- 7) mm Hg, significantly lower than that of the PH group [(34 +/- 9) mm Hg, P < 0.05], but not significantly different from that of the normal control group [(20 +/- 4) mm Hg, P > 0.05].	Simvastatin	25-36	phospholipid phosphatase 1	Mus musculus	13-17	
22971207-5	2012	RESULTS: The combination of tadalafil and simvastatin showed significantly more improvement in the mean pulmonary hypertension pressure (mPAP) and right ventricular hypertrophy compared with each monotherapy (p < 0.05).	Simvastatin	42-53	phospholipid phosphatase 1	Mus musculus	137-141	
12963647-5	2003	When rats with severe PAH received simvastatin (2 mg x kg(-1) x d(-1) by gavage) from week 11, there was 100% survival and reversal of PAH after 2 weeks (mPAP=36 mm Hg) and 6 weeks (mPAP=24 mm Hg) of therapy.	Simvastatin	35-46	phospholipid phosphatase 1	Mus musculus	154-158	
12963647-5	2003	When rats with severe PAH received simvastatin (2 mg x kg(-1) x d(-1) by gavage) from week 11, there was 100% survival and reversal of PAH after 2 weeks (mPAP=36 mm Hg) and 6 weeks (mPAP=24 mm Hg) of therapy.	Simvastatin	35-46	phospholipid phosphatase 1	Mus musculus	182-186	
25674219-7	2014	Treatment with simvastatin resulted in a significant decrease not only in mPAP and RVHI but also in a 5-HTT level in serum and BALF (P < 0.01 or 0.05) with a good correlation between the 5-HTT level and mPAP or RVHI (r = 0.693 and 0.479; 0.675 and 0.508).	Simvastatin	15-26	phospholipid phosphatase 1	Mus musculus	74-78	
25674219-7	2014	Treatment with simvastatin resulted in a significant decrease not only in mPAP and RVHI but also in a 5-HTT level in serum and BALF (P < 0.01 or 0.05) with a good correlation between the 5-HTT level and mPAP or RVHI (r = 0.693 and 0.479; 0.675 and 0.508).	Simvastatin	15-26	phospholipid phosphatase 1	Mus musculus	206-210	
24124673-10	2013	CONCLUSIONS: The combined use of beraprost and simvastatin may delay the increase of mPAP and remodeling of pulmonary vessels and inhibit right ventricular hypertrophy in pulmonary arterial hypertension rats.	Simvastatin	47-58	phospholipid phosphatase 1	Mus musculus	85-89